Amlin Plc
FOR IMMEDIATE RELEASE
AMLIN PLC
AMLIN ACQUIRES RENEWAL RIGHTS TO THE TRADE CREDIT INSURANCE PORTFOLIO OF ROYAL &
SUNALLIANCE
Amlin plc ('Amlin'), the leading Lloyd's insurer, announces today that its
managed Lloyd's Syndicate 2001, through its service company, Amlin Credit
Limited ('Amlin Credit'), has acquired the renewal rights to approximately £5
million of trade credit insurance currently written by Royal & SunAlliance
Insurance plc ('R&SA') with effect from 1 December 2003. Amlin will not acquire
any net assets nor assume liability for any previous business written by R&SA.
Chris Ventiroso, Managing Director of Amlin Credit, said:
'Amlin Credit, a leading specialist trade credit insurer, is well placed to
service and renew R&SA's existing portfolio of trade credit insurance. This
acquisition reinforces Amlin's commitment to trade credit insurance and
increases its share of the credit insurance market in the UK.'
Enquiries:
Charles Philipps, Chief Executive, Amlin plc Tel: 020 7746 1050
David Haggie, Haggie Financial Tel: 020 7417 8989
Notes to Editors:
Amlin:
Amlin plc is the largest independent business operating in the Lloyd's market
and focuses its activities on Syndicate 2001, of which it will own 100% of the
capacity from the 2004 year of account.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.